Clinical Trial Update: Investigating Gender and Sex Differences in Immune Responses Through Vaccination of Transgender and Cisgender Persons [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is investigating sex- and gender-related differences in immune responses to meningococcal B vaccination in transgender and cisgender in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Meningitis Serogroup

Snippet

Sponsor: University Ghent | Conditions: Meningococcal Meningitis, Serogroup B, Transgender Persons | Phase 4 | Status: RECRUITING